Penile Traction Therapy Results (15+ Studies) | SizeGenetics
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Penile Traction Therapy Results (15+ Studies) | SizeGenetics
-
ナレーター：
-
著者：
概要
Episode Summary
What results can you actually expect from penile traction therapy? In this episode, we break down 15+ peer-reviewed clinical studies involving over 1,000 patients — real measured outcomes, not marketing claims.
Key Findings
- Average length gain: 1.3–2.3 cm over 3–6 months of daily use across 15+ studies
- 2023 meta-analysis (Almsaoud et al.): 12 studies, 1,000+ patients, 1.9 cm weighted mean gain
- Joseph 2020 RCT: 110 participants, 94% achieved measurable length increases (1.6–2.3 cm)
- Toussi 2021 RCT: 82 men, traction group gained 1.6 cm vs. 0.3 cm control (p < 0.01)
- Safety: Zero serious adverse events reported across all major clinical trials
- Patient satisfaction: 87% would repeat therapy, 93% would recommend it
The Science
Penile traction works through mechanotransduction — the cellular response to sustained mechanical force. The same biological principle used in orthopedic limb lengthening and tissue reconstruction for decades.
About SizeGenetics
FDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.
Resources
- 📖 Full Guide: Results & Expected Outcomes
- 🔬 Clinical Studies & Evidence
- ⚙️ How Penile Traction Therapy Works
- 🛡️ Safety & Side Effects
- 📏 How to Measure Correctly
⚕️ Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.